TECH OFFERS

This innovative wearable device, integrating an actuator and a sensor, addresses a pressing issue in the field of neuromuscular disease diagnosis and management. By enabling in vivo measurements of muscular elasticity and employing machine learning models for disease severity evaluation, it offers an objective and accessible solution. The wearable conforms to the human body, facilitating quantitative assessments by correlating elastic moduli with voltage amplitude, thereby eliminating the subjectivity of traditional assessments. It significantly enhances accessibility, breaking down barriers to muscle assessment, and introduces a remote monitoring capability that allows continuous tracking of muscle health during rapid joint stretches. This technology serves medical professionals, patients with neuromuscular diseases, and rehabilitation centers by providing a reliable tool for improved diagnosis and personalized treatment plans. In summary, this wearable device represents a transformative approach to assessment of muscle-related pathophysiological conditions, offering objectivity, accessibility, and remote monitoring, ultimately enhancing the quality of care and treatment outcomes. The core components of the system include a pneumatic actuator for controlled mechanical force generation, a piezoelectric sensor to measure muscle response, and integrated machine learning models for disease severity evaluation. The system is designed to seamlessly conform to the human body, its wearability ensures patient comfort and enables a point of care continuous monitoring of muscle health, a groundbreaking advancement in the field of muscular biomechanics assessment.  This technology offers a wide array of potential applications spanning various industries. In the healthcare sector, it can help with the diagnosis and treatment of neuromuscular diseases and find use in tele-rehabilitation programs. Athletes and sports professionals can benefit from improved performance and injury prevention. This technology could help in creating customized rehabilitation equipment designed for specific patient needs and conditions, making the recovery process more effective and personalized. Routine muscle health assessments can be realized, promoting proactive healthcare management across the board. The booming wearable market and recent advances in material science has led to the rapid development of the various wearable sensors, actuators, and devices that can be worn, embedded in fabric, accessorized, or tattooed directly onto the skin. Wearable actuators, a subcategory of wearable technology, have attracted enormous interest and many wearable actuators and devices have been developed in the past few decades to assist and improve people’s everyday lives. In addition, The global diagnostic wearable medical devices market size is estimated to grow by USD 7,333.3 million at a CAGR of 15.2% between 2022 and 2027. (Source: Technavio). The system provides a substantial improvement over the current state-of-the-art in muscular biomechanics assessment. Unlike existing methods that are either subjective and qualitative or hindered by bulky, stationary instruments, this system introduces a precise, objective, and patient-friendly solution. Its wearability, facilitated by a soft textile-based cuff, enables point-of-care assessments and home-based monitoring, dramatically enhancing accessibility and convenience. Furthermore, with dynamic movement analysis it can providing valuable insights into muscle behaviour during real-world activities, a dimension largely unexplored by current techniques. These position the system as a transformative technology, poised to revolutionize the diagnosis and management of neuromuscular diseases and expand the horizons of muscular biomechanics assessment.  soft robotics, sensor, wearable, soft actuator, muscle, muscle assessment, neuromuscular assessment, biomechanics, neuromuscular diseases, actuator, wearable sensor, skin sensor Electronics, Sensors & Instrumentation, Actuators, Healthcare, Diagnostics, Medical Devices

Anti-corrosion is important for piping systems because corrosion can lead to several problems including reduced flow capacity, leaks and ruptures, contamination, increased maintenance costs and reduced lifespan. While there are several approaches to mitigate these problems, a possible approach is to utilise thermoplastic materials which are lightweight, durable, and resistant to corrosion. This technology is a thermoplastic piping system lined with HDPE/LDPE linings that is corrosion-resistant, do not generate any waste (waste material can be recycled) and has a reduced carbon footprint. The piping system is easy to assemble and install, providing long service lives due to the high-quality thermoplastic materials being deployed in the system. By laying these thermoplastic pipes underground using native soil without sand-bedding, a reduction in CO2 is achieved and offers users a sustainable piping solution against conventional piping materials. In combination with proprietary welding technologies, the technology has the lowest rate of leakages with high guarantee of preservation of drinking water quality when used in water piping systems. The technology owner is seeking for co-development and test-bedding opportunities with asset owners to integrate the technology into their infrastructure, particularly with hydrogen producing and transporting companies. The technology is a thermoplastic piping system that exhibits the following features: Efficient corrosion protection against aggressive media Excellent product properties (static puncture resistance) Long service life (minimum service life is 50 years, up to 100 years) Maintenance free – pipework is homogenous, longitudinally force-locked and leak-tight Reduced carbon footprint compared to conventional piping materials Easy to install using permanently leak-tight welding technologies Suitable for clean and efficient trenchless installation Black piping and fitting are resistant to UV and corrosion free against chemicals The technology is a thermoplastic piping system that has been successfully deployed in several industries. Possible applications include (but are not limited to): Hydrogen Plant Hydrogen transport (or transportation of natural gas) Semiconductor Photovoltaic Life Science Water and Wastewater Chemical Processing Oil & Gas Mining Power Plant Municipal Shipbuilding Environmental Engineering Irrigation Long life expectancy (up to 100 years) Maintenance free Simple and economical installation Toxic free and recyclable hdpe, high density polyethylene, thermoplastic, piping systems, anti-corrosion, corrosion resistance, low leakage, polymers, hydrogen gas pipe Materials, Plastics & Elastomers, Chemicals, Polymers, Environment, Clean Air & Water, Mechanical Systems, Sustainability, Circular Economy

Developed a cutting-edge IoT-based Irrigation System, uses proprietary algorithms and a suite of integrated hardware to intelligently optimize watering schedules based on various inputs like soil moisture levels, raining status, weather forecasts, plant species, and soil moisture needs. This smart irrigation system has been built to address the common issue of water waste and poor irrigation management in agriculture, horticulture, and landscaping sectors. Potential users for this technology are large-scale farmers, landscapers, gardening centres, municipalities managing public parks, and property management company seeking smart community solutions. This innovation aims to revolutionize irrigation management by providing an efficient, data-driven irrigation system that not only optimizes watering for different plant species but also significantly reduces water consumption and system maintenance needs. The system is composed of an array of IoT devices such as soil moisture sensors, rain sensors, water valves, and a cloud-based intelligent algorithm platform. It leverages the LoRaWAN wireless communication technology for reliable, long-range data transfer. Current State-of-the-Art solution is timer based, watering at fixed schedule, this leads to water wastage when watering continues even if the plant is hydrated. The unique multiple input-based (Eg. Soil moisture level, weather condition etc) intelligent algorithm developed is the core technology that facilitates optimal watering, to water only when the plant is in need of water. This can reduce the water consumption significantly. This system can be monitored and controlled via a user-friendly web portal, making remote management of irrigation systems possible. Additionally, the system only needs to carry out minimal number of devices/installation. The ideal collaboration partners would be IoT device manufacturers, cloud service providers, agritech companies, landscape companies and property developers. This IoT-based Irrigation System finds its use in several industries like agriculture, horticulture, landscaping, and smart community management. The technology can be deployed in large farms, public parks, golf courses, residential gardens, and greenhouses. The system forms the basis for smart products like automated sprinkler systems, drip irrigation systems, and advanced home gardening solutions. The global smart irrigation market is huge, driven by the rising need for efficient watering systems and growing concerns about water conservation. This technology, with its intelligent algorithm for optimal watering and water-saving capacity, has great potential to capture a significant share of this fast-developing market. This IoT-based Irrigation System stands apart from the current "State-of-the-Art" due to its unique, multiple input-based intelligent algorithm, enabling optimal watering based on various critical parameters, unlike traditional systems. It seamlessly integrates with LoRaWAN technology for efficient long-range communication. Its value proposition lies in its ability to significantly reduce water consumption due to minimal watering while keeping the plant healthy, installation cost and maintenance needs due to the minimal number of devices/installation required, making it a cost-effective, environment-friendly, and efficient solution in the area of irrigation management. Green Building, Sensor, Network, Building Control & Optimisation, Infocomm, Wireless Technology, Environment, Clean Air & Water, Sensor, Network, Monitoring & Quality Control Systems

In precision manufacturing, the ability to maintain optimum efficiency and accuracy is of critical importance. This AI Platform addresses these challenges by utilizing proprietary self-improving AI models for Automatic Defect Classification (ADC). This innovative solution incorporates AI Equipment Automation and Root Cause Mapping and provides a comprehensive system that significantly enhances production efficiency. The system seamlessly integrates Equipment Risk Analysis into existing alert mechanisms thus reducing downtime and increasing yield. At its core, it operates as a robust AI platform, featuring a user-centric interface for Machine Learning Operations (MLOps). This promotes recipe-free inspection while maintaining compatibility with a broad range of third-party software. The technology is modular and provides smooth productization of multiple AI solutions thereby increasing the effectiveness of defect inspection and analysis, assisting in equipment error recovery, and providing insights for process optimization. The technology offers an attractive solution for manufacturers across different industries interested in increasing their production efficiency and improving product quality. The technology features AI at its core to provide multiple AI tools in a modularized form for different inspection, maintenance, and process control related tasks common in precision manufacturing industry: High precision recipe-free AI based visual defect inspection and classification. Root cause mapping for indicating errors in upstream process. Non-intrusive equipment run status monitoring and error assist using learned behaviour from UI messages and operator interventions. Equipment health monitoring and logging. Equipment insight generation for process optimization and recipe refinement. Checklist based assistance and tracking for preventive maintenance and assists. Predictive maintenance capability. Ideal collaboration partners span semiconductor manufacturers, pharmaceutical firms and other precision manufacturing industries, hardware manufacturers for the production and upgrades of the vision systems, and research institutions focusing on AI. This technology has applications  in the manufacturing operations for the following industries: MedTech Pharmaceuticals Semiconductor Electronics Automotive Precision Engineering Aerospace With the projected growth and with production schedules becoming increasingly demanding, the ability to harness the power of artificial intelligence for predictive maintenance, process optimization, and quality control is a game-changer. These tools not only enhance the overall productivity but also enable companies to maintain a competitive edge in an ever-evolving landscape.  This technology is particularly attractive to these markets due to its ability to drastically reduce scrap rates and improve OEE (Overall Equipment Efficiency), thereby leading to significant cost savings. The growing trend of automation and AI adoption in manufacturing presents a substantial market opportunity for this technology.  The unique value proposition of the AI platform lies in its increased precision, flexibility, scalability, and seamless integration into existing manufacturing ecosystems: The solution does not require a complete overhaul of the existing setup. The solution includes a full toolset for autonomous operations - standalone AI assisted inspection, preventive maintenance, modules for reducing machine downtimes and manual assists (OEE). All actions taken are fully tracked for unique insights, root cause analysis, assisted recipe creation and process optimization. Flexible and capable of integrating techniques, like hyperspectral imaging, for insights into material properties among others. Modular and capable of adapting to various operational needs spanning different industries. Cost effective and easy integration to existing manufacturing lines. Manufacturing, Assembly, Automation & Robotics

In 2022, about 83 million patients suffer from insulin-dependent diabetes worldwide. From 2021 to 2045, this number is projected to increase by 46% globally. Despite the availability of approved insulin therapy as the standard of care, up to a quarter of these patients still suffer from poor blood glucose control, which can lead to a fatal drop in blood glucose levels. The team has developed a cell-encapsulating macro-device as an implant to reduce the risk of fatal drop in blood sugar of insulin-dependent diabetic patients. This patent-pending, injection-free cellular implant can effectively manage insulin-dependent diabetes by enabling enhanced survival of therapeutic insulin-secreting cells. After a simple under-skin insertion of the macro-device, the cells in this implant can sense the blood glucose level of a diabetic patient and secrete insulin to continuously provide injection-free, precise glucose control. The device also protects the insulin secreting therapeutic cells by encapsulating them in a hydrogel to shield them from immune attacks and alleviate the patient from the need for immunosuppression. This technology could offer a safer alternative treatment for these insulin-dependent patients who experience poor blood glucose control with conventional insulin therapy. This platform technology includes two main components: a protective hydrogel membrane and living therapeutic cells. These cells are encapsulated within the hydrogel, which has controllable pores. These pores are large enough for nutrients and therapeutic agents to pass through, allowing the cells to survive and function normally. Furthermore, the pore size is small enough to block the entry of immune cells and harmful molecules, protecting the therapeutic cells from the patient's immune system. This protection eliminates the need for lifelong use of immunosuppressants, easing the burden on the patient. Once implanted inside the patient, the therapeutic cells inside the device can sense the biological environment and secrete their therapeutic agents, typically insulin in the case of diabetes, as required. The proprietary device design also improves oxygen access for the therapeutic cells by arranging them in donut-shaped microtissues, providing more surface area for oxygen intake compared to their natural spheroidal shape. These microtissues are then organized into arrays to prevent aggregation, enhancing survival of the therapeutic cells and potentially prolonging treatment duration without the need for additional agents or accessories. The technology development is currently focusing on treatment for insulin-dependent diabetes. In addition to this indication, it could serve as a platform technology for the treatment of other hormone-deficiency diseases by encapsulating different types of therapeutic cells to secrete missing hormones of interest. The applicable indications include, but are not limited to, hemophilia A and thyroid disorder. With 83 million patients worldwide suffering from insulin-dependent diabetes in 2022, there is an urgent unmet need for a safer alternative treatment for patients unresponsive to insulin therapy. The proposed cellular therapy has the potential to fulfil this need, and there is no similar treatment already approved and available in the market. Targeting the young insulin-dependent patient population (Type 1 Diabetes) experiencing poor blood glucose control and able to afford the treatment, it is estimated that the service obtainable market in the United States could achieve an annual revenue of approximately 70 million USD. A similar estimation values the Chinese market at 37 million USD annually.  The  macro-device implant is designed to provide continuous and precise blood glucose control without requiring manual intervention and injection. The proprietary hydrogel design provides protection from immune rejection as alleviating the patient from the burden of lifelong immunosuppressant usage. The device design also potentially improves the survival of encapsulated cells, promising a sustainable and prolonged efficacious duration without overburdening the patient with additional accessories. diabetes, type 1 diabetes, injection free insulin delivery, insulin, insulin delivery, cell therapy, therapeutics, stem cells, hydrogel, implant, implant device Healthcare, Medical Devices, Pharmaceuticals & Therapeutics

Patients who have stroke, brain injuries, cerebral palsy, arthritis or suffer from other neurological disorders often experience motor impairments; patients with delayed or lack of rehabilitation suffer from more severe physical sequelae, such as, spasticity and muscle atrophy, which decreases their level of independence It has been reported by World Health Organisation, that the need for rehabilitation continues to grow worldwide, especially in low- and middle income countries. The demand for rehabilitation services already exceeds availability, leaving a large unmet need. Longer life expectancies and increasing survival rates for those with severe disability, coupled with the rising prevalence of chronic diseases means that globally there will be an increase in the health burden associated with limitations in functioning. For both the patients and therapists, there is a need for efficient models of rehabilitation care are needed. This invention is of a robotic manipulator that can assist or be programmed to move or mobilize patients’ limbs or joints repetitively during rehabilitation or to perform daily tasks, for e.g., of gripping a cup, bowl or utensil, in a safe, reliable and effective manner. The device can be used in a clinical and/or at-home setting. This invention is of a hybrid robotic manipulator that consists of both soft and rigid materials, with a portable base, modular design and sensing elements integrated for more functions. The technology was developed to aid physiotherapists in doing repetitive rehabilitation motions for bed-ridden patients. This innovative solution for patients allows them to regain their upper limb motor functions and improve their quality of life. The technology can be used as an upper limb rehabilitation system that is portable, comfortable, lightweight, and user-friendly. With its versatility and flexibility, this system can be deployed in places where assistance for rehabilitation of the patients is needed, such as hospitals, rehabilitation centres and elder-care centres to do simple repetitive rehabilitation motions for the patients, such as shoulder flexion/extension, shoulder abduction/adduction, elbow flexion/extension, etc.  The global rehabilitation robots market was valued at USD 226.0 million in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 17.3% from 2022 to 2030 (Source: Grand View Research). The growth can be attributed to the rising per capita healthcare spending and rapid adoption of technologically advanced equipment in the healthcare sector. The rising prevalence of stroke and the rapidly growing population of older adults are some of the key driving factors responsible for the growth. Technological advancements are also playing a major role in supporting industry growth. Furthermore, increasing disorders such as cumulative trauma disorder, repetitive strain injury, and occupational overuse syndromes further impact the market positively. A large population with musculoskeletal disorders, spinal cord injury, and others tend to move to hospitals for rehabilitation services, thereby boosting the growth of the segment. In addition, surging awareness regarding technologically advanced systems, along with a rise in the number of FDA approvals on medical exoskeletons, is anticipated to drive the segmental growth. Couple this, with the acute shortage of qualified physiotherapists to address the expected increase in patient demand, indicates a strong market potential for assistive rehabilitation robotic technologies such as this invention. This hybrid robotic arm ensures better safety during human-robotic interactions, and demonstrated higher force, versatility and portability compared to existing robotic arms. The key feature of this invention provides: Better safety: The robotic arm was created with both rigid and soft materials. The core of the hybrid robotic arm was made of aluminium as the supporting structure, and the outer layer was made of fabric air pockets as the protective material. Compared to traditional rigid robotic arms, the hybrid robotic arm ensures better safety during human-robotic interactions, as well as higher portability which increases user convenience. Reconfigurable modular robotic arm: All modules of the hybrid robotic arm are exchangeable, which allows the robotic arm to exhibit different arm length and various configurations such as beam-joint-beam and beam-beam-joint, according to the application requirements. Integrated sensing elements for easier control: Machine Learning based sensing elements are integrated to the system to allow a playback learning capability in which the physiotherapists can teach the system to perform a rehabilitation motion along a desired path of motion, and to provide data for the physiotherapists to track and analyze rehabilitation progress of the patients Physiotheraphy, Soft Robotics, Robotics, stroke rehabilitation, rehabilitation, robots, rehabilitation robots, modular, robotic arm, robotic manipulator Healthcare, Medical Devices

This technology portfolio covers wearable sensing and haptics for Virtual Reality (VR). The wearable sensors can provide gesture-based control in VR without the need for cameras, providing interactive control for VR for lower end headset. The sensor use electronic textiles and a patented sensing scheme that requires no additional electronics except a microcontroller. They present ultralow latency (<1ms), can distinguish between wearer and non-wearer and have exceptional noise rejection. The haptics technology allows for simulation of resistance and micro sensations on the fingers and palm. This is crucial for applications like surgical training, as surgeons routinely rely on their sense of touch in real world scenarios. The jamming technology uses textile-based actuators and pneumatics, making it the lightest wearable technology for haptics. Sensing: Textile-based wearable sensors woven into gloves. Custom microcontroller mounted on the glove. Proprietary signal conditioning and processing algorithm. Haptics: 3D-printec micro haptics actuators, as well as 3D printed+ fabric-based jamming actuators.Pnuematics pressure source, valves and control box. VR-based training is the main target for the haptics. The tech owner has signed LOIs with studios with downstream medical clients. The patented sensing methods allows for ultralow latency (<1ms) sensing with almost no hysteresis, which is unique in case of wearable soft sensors. This makes them ideal for use in applications like gaming and other wearable input devices, where other soft sensor leave a lot to be desired for a good user experience.   Sensing: Gaming and VR interaction- without the need for extra cameras: the wearable sensing provides a cheaper alternative to additional headset cameras. Haptics: Medical training professionals- haptics is crucial for applications like surgical training where dexterity needs to be trained. Current applications of VR can only train procedures. XR based training is becoming popular as it saves up to 80% cost compared to traditional methods and improves retention by up to 4x. The market for XR hardware is already a S$2.6B market and growing rapidly. The market is project to grow 40-50% YOY over the next 5 years. This is greatly being aided by addition of application layers such as OpenXR that allow for cross-compatibility between hardware such as the devices we are building. The sensor can distinguish between wearer and non-wearer, has exceptional noise resistance, and the system has extremely low power consumption owing to the sensing method used. The jamming haptics technology uses fabric-based jamming which is the lightest in-class for wearables. This makes it ideal for applications where dexterity is requited- such as VR surgical training. The micro-haptics uses 3D printed designs that supply higher force output at lower pressures due to their patented multi-layer design. Infocomm, Internet of Things

Systemic drug administration has conventionally been prescribed to alleviate persistent local inflammation which is prevalent in chronic diseases. However, this approach is associated with drug-induced toxicity, particularly when the dosage exceeds what is necessitated from the pathological conditions of the diseased tissues. This technology developed is a novel drug delivery technology that is activated to enable the release of appropriate drug payload according to the patient’s condition on the level of disease severity. The drug delivery system is a modular hybrid hydrogel carrier encapsulating the required anti-inflammatory drug which is triggered to release upon exposure to elevated markers of inflammation such as increased protease activity which is commonly upregulated in inflammatory diseases.   The technology has been validated for its material, safety, and toxicity studies on ex vivo exudates of clinical samples, in vivo wound model, and arthritis diseased mouse model. The primary targeted indication is Rheumatoid arthritis based on its significant disease unmet need and market size. It aims to become a platform technology as an effective therapy against chronic inflammatory diseases such as inflammation bowel diseases, chronic wounds and topical application. The convenience of the technology offers significant societal benefits, particularly for ageing populations where the incidence of pain and inflammation arising from diseases becomes prevalent with age while potentially eliminating adverse side effects from traditional delivery of drug administration.  The technology owner is seeking for collaborations with clinicians, biopharma, biotech companies looking for novel drug delivery systems. The platform technology is based on a hydrogel system with a proprietary modular design for which drug component and inflammation-sensing component can be selected and tailored based on the profile of an inflammatory disease of interest. Key features of this platform drug delivery technology are: Modular in design Immuno-compatible Versatile for both injectable into joints and topical application on wound This drug delivery system is formulated into an injectable pain-relieving gel for arthritic patients. With a single injection into the joints of arthritis patients, the therapeutic drug within the hydrogel formulation will be released at a dosage matching the intensity and frequency of inflammation flares to achieve prolonged control of inflammation and pain. This analgesic product solution can help arthritic patients avoid frequent steroid injections while maintaining pain-free joints with minimal risk of adverse side effects. The stage of the technolgy can be applied with Steroidal and Non-steroidal anti-inflammatory drugs (NSAIDs) currently. This drug delivery platform offers a versatile platform for biomarker dependant drug dose release and delivery at appropriate inflammation site via either an injectable or topical application to effectively manage long-term inflammation seen in chronic conditions. The technology can be applied to create precision therapeutics in injectable or topical formulation to treat chronic inflammation conditions such as arthritis, skin inflammatory diseases, Inflammatory Bowel Diseases (IBD), chronic wounds and Chronic Obstructive Pulmonary Diseases (COPD) which can be potentially expanded to other areas including eye, skin and dental as a pain control for inflammation and the possibility of encapsulating proteins and peptides. The estimated Total Available Market (TAM), which is the global rheumatology therapeutics market, was USD 48.4 billion in 2020 with an expected growth to USD $64.4B by 2028, expanding at a CAGR of 3.1% during this forecast period. The Serviceable Available Market (SAM), estimated base on corticosteroid market for management of arthritic flare as the primary indication, accounts for 25% of joint-pain injection market which will be worth USD $9.2 billion by 2030. The technology is in PCT national regional phase entry for several markets including USA, China, EU, Japan, Korea, and Australia.  Key features of this precision medicine: Effective management of inflammatory condition Minimize adverse side effects Minimize frequency of drug administration Precision Medicine, Drug Delivery, Anti-inflammation, Chronic disease, Hydrogel, Arthritis Healthcare, Medical Devices, Pharmaceuticals & Therapeutics

Singapore has a high consumption of fruits and vegetables, both locally produced and imported, and a significant portion of the total waste generated is derived from fruits and vegetables. These fruits and vegetables contain untapped nutritional and functional properties that can be upcycled into higher value products. This institute of higher learning has developed a technology with the know-how to cultivate microorganisms and a series of zero-waste extraction and purification methods to maximize the value of fruit peels into functional food ingredients.  This technology is designed for three types of industry players: i) fruit vending/processing industry with abundance of good quality fruit by-products; ii) waste management industry with technologies to value add to the by-products; and iii) start-ups with keen interest to upcycle by-products into novel food ingredients. The technology is a sustainable process and here are some key features: Zero waste solution – achieving circular economy Low-carbon economy, reduced waste during manufacturing Easy to assemble using off-the-shelf commercial-ready equipment Low CAPEX, modular installation Simple method – any technician with basic training and carry out the process Scalable – abundance of fruit by-products to achieve economies of scale A reactor for pilot scale testing at a reasonable cost has been fabricated for collaborators to tap on. Food-grade microbial protein: A protein-rich source of food ingredient with functional properties to be applied into beverages, confectionery, plant-based meats Pectin from fruit peels: A finished product upon extraction process, it is rich in soluble dietary fiber that can be used as natural thickener or in jam/sauces and beverages. Cleaning agents: Antimicrobial properties were observed in the fruit peels post extraction Good quality fruit by-products from fruit industry are valuable resources for upcycling. These materials are currently disposed  by incineration. With the high moisture content of fruit peels, incineration is energy-intensive leading to higher CO2 emission. This technology produces valuable food ingredients such as protein and dietary fiber, contributing to both food security and circular economy. microbial protein, dietary fiber, dietary fibre, fuit by-product, fruit peel, zero waste, sustainable food ingredients, fruit waste, food waste, upcycle, food valorisation Waste Management & Recycling, Food & Agriculture Waste Management, Sustainability, Circular Economy, Food Security